期刊文献+

人参总皂苷渗透泵片体外释药的影响因素 被引量:2

Investigation of the factor influencing the release rate of gensengosides osmotic pump tablets
下载PDF
导出
摘要 目的建立测定人参总皂苷渗透泵片体外释放度的方法,考察不同因素对该剂型体外释药行为的影响规律。方法用UV法和体外释放度试验,考察渗透泵片在不同溶出方法、释放介质、搅拌桨转速下的累积释放度。结果溶出方法、搅拌桨转速、溶出介质pH3.5~7.6对渗透泵片体外释放行为无显著影响;渗透压对体外释放行为有显著影响。结论确定了不同因素对渗透泵片体外释放度的影响规律。 OBJECTIVE To investigate the method of the examinination of the release of gensenosides osmotic pump tablets,and to estimate the release in vitro.METHODS The cumulative release of gensenosides osmotic pump tablets in vitro was investigated with different dissolution method,different release medium and different agitating rate,using ultraviolet spectrophotometry.RESULTS The method to examine the in vitro release of gensenosides osmotic pump tablets was established.The release rate was not influenced by the d...
机构地区 成都中医药大学
出处 《华西药学杂志》 CAS CSCD 北大核心 2008年第4期438-439,共2页 West China Journal of Pharmaceutical Sciences
关键词 人参总皂苷 渗透泵片 体外释放度 Gensenosides Osmotic pump tablet Release in vitro
  • 相关文献

参考文献6

二级参考文献16

  • 1[1]Kuczynski AL, Ayer AD, Wong PSL, et al. Oral hypoglycemic glipizide granulation [P]. US: 5024843,1991-06-18.
  • 2[2]Kuczynski AL, Ayer AD, Wong PSL, et al. Dosage form for administering oral hypoglycemic glipizide [P].US: 5545413, 1996-08-13.
  • 3[3]Swanson DR, Barclay BL, Wong PSL, et al. Nifedipine gastrointestinal therapeutic system [J]. Am J Med, 1987,83(suppl 6B):3-10.
  • 4[4]Vinod PS, Yi TS, Pradeep S, et al. In vitro Dissolution profile comparison-statistics and analysis of the similarity factor, f2 [J]. Pharm Res, 1998,15(6):889-896.
  • 5Seta Y.Design and preparation of captopril sustained-release dosage forms and their diopharmaceutical properties [J].International Journal of Pharmaceutics,1988,41:245-254.
  • 6Hideaki Otsuka, Yukio Morita, Yukio Ogihara.The evaluation of Ginseng and its congeners by droplet counter-current chromatography (DCC)[J].Planta Medica,1977,32:9
  • 7Bombardelli E, Bonati A, Gabetta A,et al.Gas-liquid chromatographic method for determination of ginsenosides in Panax Ginseng[J].J chromatogr, 1980,196:121
  • 8希尼维斯A 高诚 海滨 张源详 译.心血管疾病内科治疗学 [M].北京:人民卫生出版社,1988.99-115.
  • 9万雅各.巯甲丙脯氨酸的临床应用[J].江西医药,1986,21(2):156-158.
  • 10Kozo Takayama,Mikito Fujikawa,Tsuneji Nagai. Artificial Neural Network as a Novel Method to Optimize Pharmaceutical Formulations[J] 1999,Pharmaceutical Research(1):1~6

共引文献60

同被引文献43

  • 1颜廷旭,杨星钢,程洁,王启明,潘卫三.四逆散双层渗透泵控释片片芯单因素考察[J].中国药剂学杂志(网络版),2010(2):64-73. 被引量:6
  • 2曲昌海,汤韧,高永良.不同溶解性药物口服渗透泵片片芯的处方设计[J].中国医院药学杂志,2005,25(12):1164-1165. 被引量:6
  • 3张丹,孙英华,刘艳,方金玲,张永强,何仲贵.均匀设计法制备苦参碱渗透泵型控释片[J].沈阳药科大学学报,2007,24(1):16-19. 被引量:9
  • 4赵学玲,李强,龚显峰,李三鸣.微孔渗透泵片的药物传递机制[J].药学学报,2007,42(2):226-229. 被引量:18
  • 5刘志东,刘套,高国义.丹酚酸B渗透泵控释片的制备[C].全国中药创新与研究论坛·论文集,2009,233-239.
  • 6Verma R K, Mishra B, Garg S. Osmotically controlled oral drug delivery [J]. Drug Dev lnd Pharm, 2000, 26(7): 695-708.
  • 7Vema R K, Krishna D M, Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems [J]. J Controlled Release, 2002, 79(1/3): 7-27.
  • 8Zentner G M, Rork G S, Himmelstein K J. The controlled porosity osmotic pump [J]. J Controlled Release, 1985, 1(4): 269-282.
  • 9Zentner G M, Rork G S, Himmelstein K J. Osmotic flow through controlled porosity films: an approach to delivery of water soluble compounds [J]. J Controlled Release, 1985, I(2): 217-229.
  • 10Ozyazic M, Gokce E H, Ertan G. Release and diffusional modeling of metronidazole lipid matrices [J]. Eur J Pharm Biopharm, 2006, 63(3): 331-339.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部